XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Unaudited Interim Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
  Common Stock
Additional Paid-in Capital
Retained Earnings / (Accumulated Deficit)
Accumulated Other Comprehensive   Income (Loss)
Total Pruco Life Insurance Company Equity
Noncontrolling Interests
Total  Equity
Begining Balance at Dec. 31, 2023   $ 2,500 $ 5,052,602 $ (551,471) $ (30,961) $ 4,472,670 $ 30,194 $ 4,502,864
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Contributions from noncontrolling interests             25,310 25,310
Contributed (distributed) capital-parent/child asset transfers     5,722     5,722   5,722
Comprehensive income (loss):                
Net Income (Loss) $ (574,395) [1]     (575,576) [2]   (575,576) [2] 1,181 [2] (574,395) [2]
Other comprehensive income (loss), net of tax (412,481)       (412,481) [2] (412,481) [2] 0 [2] (412,481) [2]
Total comprehensive income (loss) (986,876)     (575,576) (412,481) (988,057) 1,181 (986,876)
Ending Balance at Mar. 31, 2024 [2]   2,500 5,058,324 (1,127,047) (443,442) 3,490,335 56,685 3,547,020
Begining Balance at Dec. 31, 2024 4,701,980 2,500 4,923,299 272,519 (601,877) 4,596,441 105,539 4,701,980
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Contributed capital     220,000     220,000   220,000
Contributions from noncontrolling interests             52,350 52,350
Contributed (distributed) capital-parent/child asset transfers     26,303     26,303   26,303
Comprehensive income (loss):                
Net Income (Loss) 134,526     129,569   129,569 4,957 134,526
Other comprehensive income (loss), net of tax 332,968       332,968 332,968 0 332,968
Total comprehensive income (loss) 467,494     129,569 332,968 462,537 4,957 467,494
Ending Balance at Mar. 31, 2025 $ 5,468,127 $ 2,500 $ 5,169,602 $ 402,088 $ (268,909) $ 5,305,281 $ 162,846 $ 5,468,127
[1] Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information.
[2] Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information.